STEFANIE DUBICKI: Open Payments
NPI 1730723362 · STOKESDALE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$387 in 25 payments from 9 companies in 2025. Trend: 2023 $3,997 · 2024 $478 · 2025 $387
Food & beverage: $387
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 14 | $159 |
| Novo Nordisk Inc | 3 | $73 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $43 |
| Sumitomo Pharma America, Inc. | 1 | $27 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| PFIZER INC. | 1 | $17 |
| Collegium Pharmaceutical, Inc. | 1 | $15 |
| Medtronic, Inc. | 1 | $15 |
Products named: General - Pain Management, Wegovy, CAPLYTA, GEMTESA, Rybelsus, XIFAXAN, Auvelity, PAXLOVID.
Industry payments across NC — which companies pay providers there.
